The manuscript shows that HPV-16 E5 down-regulates and physically interacts with HLA class I via the first 30 N-terminus amino acid residues. This N-terminus domain is capable by itself of retaining HLA class I in the Golgi apparatus and preventing the anterograde transport of the complex to the cell surface.
Introduction
Human papillomaviruses (HPVs) infect mucosal and cutaneous epithelia, and induce lesions that can persist and progress to cancer. The mildest forms of HPV disease are benign hyperproliferative lesions, known as warts or papillomas. In most cases these lesions are cleared after several months following activation of the host immune system against viral antigen 1 . However, due to the ability of certain types of HPVs to avoid immune clearance, occasionally the lesions do not regress and can progress to cancer. This is especially true for HPV type 16 which is involved in the majority of cases of HPV-induced cervical cancers 2 .
The ability of the virus to avoid immune clearance is due to several factors dependent on the virus life cycle, but also on active mechanisms operated by the viral proteins to counteract the host immune attack. Elimination of virally infected cells requires cytotoxic T-lymphocytes (CTL) that can recognise and kill virally infected cells via ligation of their receptor to major histocompatibility class I complex (MHC I; HLA I in humans) bound to viral peptides on the surface of infected cells 3 .
The probe was 5'aacattactggcgtgctttttgctttgct3' in all cases. For ß-actin, primers and probe were commercially available (Applied Biosystems). Standard curves were generated using 10-fold serial dilutions of each template DNA, to quantify the relative levels of E5 and β-actin mRNA.
Semi-quantitative RT-PCR
Real time RT-PCR did not work for E5 Del1 as no appropriate forward primer could be identified outside the first hydrophobic domain that matched the probe. Therefore, to quantify the levels of E5 Del1, semi-quantitative RT-PCR was performed 9 . The Del1 F primer was 5'ctgcttttgtctgtgtctacata3' and the R primer was 5'tataatatatacaataaaacacctaa3'. RT-PCR was performed using an ABI prism 7700 sequence detector for 20, 25, 30 or 35 cycles. The same amplification protocol was used with E5 wt and R30 as controls. The RT-PCR products were run on gels, the bands scanned with MagicScanner 32-v4.3 and quantified with ImageQuant v5.2 software.
Western blotting
Fifty µg of protein lysates from HaCaT cell harbouring empty vector (Control), expressing Del1 or E5, were electrophoresed, and transferred to nitrocellulose membrane. The membranes were blocked and incubated with mAb HA11 (1/500 dilution; Sigma) for 1 hour, washed and incubated with anti-mouse IgM-HRP (1/5000; Oncogene CalbiochemNovabiochem International). After 1 hour the membranes were washed and bound antibody was detected by enhanced chemoluminescence staining (ECL) (Amersham Pharmacia Biotech).
Flow cytometry
Detection of HLA I by flow cytometry was performed essentially as previously described 4 .
Briefly HaCaT cells and cells expressing E5 and mutants were incubated with anti-human HLA class I monoclonal antibody (mAb) W6/32 (1/100; Serotec), at 4°C for 30 min, and then with anti-mouse IgG-FITC (1/100; Sigma) at 4°C for 30 min in the dark.. After washing the cells were analysed by flow cytometry. If the flow cytometry analysis was not performed immediately, the cells were re-suspended in 500μl of 3.4% paraformaldehyde in PBS and kept at 4°C. For the detection of intracellular HLA I, the cells were permeabilised with 0.5% Saponin (Sigma) in PBS-B and incubated with the primary antibody as described above. All samples were examined in a Beckman Coulter EPICS Elite analyser equipped with an ion argon laser with 15 mV of excitation at 488 nm. The data were analysed using Expo 2 software.
Immunofluorescence
Detection of HLA I by immunofluorescence was performed essentially as previously described 4 . Briefly, cells were washed and fixed in fixing solution (19ml PBS, 1ml 37% formaldehyde and 0.4g sucrose) for 10 minutes at room temperature (RT). After fixation, cells were incubated in permeabilising solution (19ml PBS, 1ml 10% NP40 and 0.4g sucrose)
at RT for 10 minutes, incubated with mAb W6/32 (1:50 dilution) for 1 hour at room temperature and then with anti-mouse IgG-FITC (1/500;Sigma) at 4°C for 1 h in the dark.
Following three final washes with PBS, the slides were mounted in Citifluor TM (glycerol/PBS solution, Sigma) and analysed with a Leica TCS SP2 fluorescence confocal microscope (Leica-microsystems, Heidelberg Germany).
Co-localisation of Golgi apparatus and E5
HaCaT cells were transiently transfected with 0. Cells were analysed with a Leica TCS SP2 confocal scanner microscope. Images were acquired and merged using Leica confocal software.
Co-immunoprecipitation of E5 and HLA heavy chain in HaCaT cells
Control or E5-HaCaT cells were lysed in RIPA buffer (50mM Tris HCl pH 7.5, 150mM
NaCl, 1% Nonidet P40, 0.5% NaDoc, 0.1% SDS) containing a cocktail of protease inhibitors (Roche, Lewes, UK). 100 μg of protein lysate were immunoprecitated with 50 µl of mAb HA11 (1:10 diluition; Sigma) against the HA-tag of E5 and then incubated at 4°C overnight.
After that, protein G-sepharose bead suspension (Sigma) was added for 1 h at 4 o C.
Following four washes in RIPA buffer the sepharose beads were resuspended in 20 μl of SDS loading buffer, heated at 75 o C for 10 min, and then electrophoresed in 12% NuPAGE gels (Invitrogen). Proteins were transferred onto nitrocellulose membranes and immunoblotted with 10 µl mAb HC10 against HLA-A, B, C (1:1000 dilution; Cancer Research, UK).
In vitro transcription/translation and co-immunoprecipitation
HLA heavy chain A2 cDNA sequence in pAL356 was excised and re-cloned in pBluescript II SK (+) (Stratagene); HLA heavy chain A1 or B8 cDNA sequences in pRSV5-neo were excised and re-cloned in pGEM-11Zf (Promega, UK). All HLA heavy chain plasmids were a gift from Dr S. Man, University of Cardiff, UK. HPV-16 E5 or E5 mutants, and A1, A2 or B8 were in vitro transcribed-translated using the TNT® T7 Quick Coupled 
E5 interacts with the HC of different HLA I haplotypes
To investigate whether E5 interacts with different HC, and as the in vitro interaction between E5 and HC reflects the interaction occurring in vivo, we performed in vitro co-precipitation experiments with E5 and A1 or B8 HC. In both cases, E5 and HC co-precipitated when either mAb HC10 or mAb HA11 was used ( Figure 1D -G, lanes 7). Although a faint band corresponding to A1 or B8 HC was detected with mAb HA11 even in the absence of E5, the band was stronger when E5 was present, particularly in the case of B8, giving confidence that the co-precipitation reflects a genuine interaction. As E5 interacts with A3 in HaCaT cells, and with A1, A2 and B8 in vitro, we conclude that the interaction between E5 and HC is likely to take part with most, if not all, classic HLA I alleles.
Characterisation of E5 mutants
HPV-16 E5 is a transmembrane protein containing three well defined hydrophobic regions, of which the first one is the longest 12, 13 . To determine the E5 domain responsible for downregulation of surface HLA I, deletion mutants of E5, lacking helical domain 1, 2 or 3, were assayed for their ability to retain HLA I in the GA. Mutant R79 lacks the last five C-terminal amino acids, A54 lacks the complete third hydrophobic domain, V36 and R30 lack the second and third hydrophobic domains, and Del1 lacks the first hydrophobic domain ( Figure   2A ). Before any analysis of the E5 mutants was carried out, we made sure that their expression and cellular localisation were not different from those of E5 wt. wt and mutants are shown in Figure 2B . The levels of E5 wt or mutant RNA were very low, approximately four orders of magnitude less than actin RNA as previously found 4 ; however, they were comparable among clones, ranging approximately from 0.02 to 0.03 pg per 100ng
RNA.
Del1 RNA could not be amplified by Q-RT-PCR because no forward primer compatible with the probe could be identified outside the first hydrophobic domain, so semi-quantitative RT-PCR was used instead. Also in this case, there was no appreciable difference in the amounts of RNA between E5 wt and mutants, including Del1 ( Figure 2C ).
Cellular localisation of E5 proteins.
Given the very low expression levels of E5, it is not possible to determine the cellular location of the protein by cytoimmunofluorescence.
Therefore we decided to analyse E5 location by the use of GFP-E5 fusion proteins. The correct cellular localisation of GFP-E5 fusion proteins has been reported 14 . HaCaT cells were transiently transfected with plasmids encoding GFP-fusions of E5 or E5 mutants or empty EGFP vector; the GA was visualised by using the Golgi marker BODIPY-TR-ceramide and the nucleus was stained with DAPI. The localisation of the GFP-fusion proteins was determined by three-colour confocal microscopy. There was no discernible difference in localisation between E5 and its mutants; in all cases, the E5 proteins were localised in the endomembranes, mainly the GA, as shown by the merged images ( Figure 2D ).
The first hydrophobic domain of E5 is responsible for surface HLA I down-regulation
As E5 wt and mutants were expressed to comparable levels and localised to similar cellular compartments, we next investigated which E5 domain(s) was responsible for prevention of Taken together, these results conclusively show that E5 both physically interacts with HC and down-regulates surface HLA I via its first hydrophobic domain.
Discussion
As is the case for the E5 oncoprotein of BPV [9] [10] [11] 16 , the E5 oncoprotein of HPV-16 prevents the transport of HLA I to the cell surface and retains the complex in the Golgi apparatus 4 .
We have argued that the Golgi retention of MHC I by BPV-4 E5 is due to at least two events:
the impaired acidification of the Golgi apparatus and the physical interaction of E5 with the heavy chain of MHC I. We have recently reported that BPV E5 interacts with the HC of bovine MHC I via its Cterminus domain 10 . This contrasts with the results presented here with HPV-16 E5 but this difference is not surprising. Despite their differences in length and presumed conformation, BPV E5 and HPV E5 share numerous functional similarities, one of them being the interference with the proper function of 16k ductin (and therefore of the vacuolar ATPase) 7 .
HPV-16 E5 interacts with
BPV E5 and HPV-16 E5 interact with 16k subunit c via different E5 domains: BPV E5
interacts via its 17 th amino acid residue (Q in BPV-1 E5, N in BPV-4 E5; 18, 19 whereas HPV-16 E5 interacts via its second and third hydrophobic domains 8, 20 . Thus, the same effects, such as down-regulation of MHC I and disablement of the proton pump, can be achieved by distinct physical interactions with HC and subunit c, respectively.
The interaction between HPV-16 E5 and 16k subunit c has been deemed responsible for the impaired functioning of the pump and the consequent lack of acidification of the endomembrane compartments 21, 22 . Alkaline pH in the endolysosomes leads to delayed degradation and faster recycling of the epidermal growth factor receptor 22, 23 , thus promoting increased cell proliferation. Studies with deletion mutants, including those employed by us here, have mapped the 16k-interacting domain of HPV-16 E5 to a relatively large region of E5 encompassing the second and third hydrophobic domains 8, 20 . The observation that HPV-16 E5 interacts with HC and 16k via different domains suggests that E5 can in principle bind the two cellular partners at the same time, thus simultaneously promoting immunomodulation and cell transformation, partly explaining the pleiotropic effects of E5 expression.
We have commented before on the functional similarity between HPV-16 E5 and HIV-1 Nef.
Both proteins prevent transport of classical HLA I to the cell surface in their natural host cells type 24 , bind to the HLA I HC via the same domains needed for HLA I down-regulation 25 and neither down-regulate non-classical HLA I 26 ; both bind 16k subunit c 27 and induce cytoskeletal rearrangements 28, 29 , and induce epidermal hyperplasia when expressed in the basal layer of the skin of transgenic mice 30, 31 . These similarities are intriguing and point to a process of "convergent evolution" of these two proteins encoded by such different viruses. In all panels, the co-precipitated E5, E5 mutants and HC bands are indicated by black dots; the other bands originate from the translated E5 protein (see input lanes) and may represent multimers of E5. 
